Skip to main content
Learn How to Analyze Your Market and Trading Plan
Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.
Download Your FREE Options Trading Strategy Guide today!
pixel

ICO Insider Trading (iCo Therapeutics)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$105,237.40
Insider Selling (Last 12 Months): C$0.00

iCo Therapeutics Insider Trading History Chart

iCo Therapeutics Share Price & Price History

C$0.11
+0.30 (1.20%)
As of 03/19/2021 06:41 PM ET
Days: 30 | 90 | 365
Learn How to Analyze Your Market and Trading Plan
Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.
Download Your FREE Options Trading Strategy Guide today!
pixel

iCo Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/22/2020William Wasyl JaroszDirectorBuy272,000C$0.03C$9,492.801,248,556
9/11/2020William Wasyl JaroszDirectorBuy273,556C$0.35C$95,744.60976,556
5/23/2018Andrew Rae RaeDirectorBuy250,000C$0.04C$10,000.00
5/18/2018Andrew Rae RaeDirectorBuy500,000C$0.04C$20,000.00
See Full Table
iCo Therapeutics logo
iCo Therapeutics Inc., a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat ocular and infectious diseases. Its in-licensed product candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat ulcerative colitis and bullous pemphigoid; and Oral AmpB Delivery System, an oral formulation of Amphotericin B that is in Phase 1b clinical trial for the treatment of systemic fungal and parasitic infections. The company was incorporated in 2005 and is headquartered in Vancouver, Canada.
Read More on iCo Therapeutics

Today's Range

Now: C$0.11
C$0.10
C$0.11

50 Day Range

MA: C$0.11
C$0.11
C$0.11

52 Week Range

Now: C$0.11
C$0.04
C$0.16

Volume

1,309,660 shs

Average Volume

3,162,437 shs

Market Capitalization

C$19.01 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of iCo Therapeutics?

iCo Therapeutics' top insider shareholders include:
  1. William Wasyl Jarosz (Director)
Gain the Knowledge You Need to Successfully Trade Futures Markets
Our Technical Analysis Guide will give you the insight into today’s fast-moving markets. It’s designed to give you a head start in learning the basics of various TA tools and techniques.
Download Your Complimentary Technical Analysis Guide TODAY!
pixel